What is the current valuation of the Massage Oil Market as of 2024?

The Massage Oil Market was valued at 4.099 USD Billion in 2024. Read More

What is the projected market valuation for the Massage Oil Market in 2035?

The market is projected to reach 7.076 USD Billion by 2035. Read More

What is the expected CAGR for the Massage Oil Market during the forecast period 2025 - 2035?

The expected CAGR for the Massage Oil Market during 2025 - 2035 is 5.09%. Read More

Which companies are considered key players in the Massage Oil Market?

Key players include Johnson's, Neutrogena, Burt's Bees, The Body Shop, Aveda, Kiehl's, L'Occitane, Weleda, and Bio-Oil. Read More

What are the main application segments of the Massage Oil Market?

The main application segments include Professional Massage, Personal Massage, and Beauty and Spa Treatments. Read More

How do the valuations of base oils in the Massage Oil Market compare?

Base oil valuations include Sweet Almond Oil at 0.9 to 1.6 USD Billion, Grapeseed Oil at 0.8 to 1.4 USD Billion, and Coconut Oil at 1.2 to 2.0 USD Billion. Read More

What is the projected growth for the Professional Massage segment by 2035?

The Professional Massage segment is projected to grow from 1.5 USD Billion in 2024 to 2.5 USD Billion by 2035. Read More

Which active ingredients are expected to drive growth in the Massage Oil Market?

Active ingredients such as Essential Oils, Plant Extracts, and Vitamins and Minerals are expected to drive growth. Read More

What target areas are most relevant in the Massage Oil Market?

Relevant target areas include Full Body, Muscle Relief, Skin Care, and Aromatherapy. Read More

Massage Oil Market

Q: What therapeutic benefits are associated with massage oils?

Therapeutic benefits include Relaxation and Stress Relief, Pain and Inflammation Reduction, and Improved Sleep Quality. Read More

ID: MRFR/PCM/38884-HCR

100 Pages

Tejas Chaudhary

Last Updated: May 15, 2026

Massage Oil Market Size, Share & Industry Analysis Research Report By Application (Professional Massage, Personal Massage, Beauty and Spa Treatments), By Base Oil (Sweet Almond Oil, Grapeseed Oil, Coconut Oil, Jojoba Oil, Sunflower Oil), By Active Ingredient (Essential Oils, Plant Extracts, Vitamins and Minerals), By Target Area (Full Body, Muscle Relief, Skin Care, Aromatherapy), By Therapeutic Benefits (Relaxation and Stress Relief, Pain and Inflammation Reduction, Improved Sleep Quality, Increased Circulation, Skin Hydration and Nourishment) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Packaging & Transport, BY Application (USD Billion)
  1. 4.1.1 Professional Massage
  2. 4.1.2 Personal Massage
  3. 4.1.3 Beauty and Spa Treatments
2. 4.2 Packaging & Transport, BY Base Oil (USD Billion)
  1. 4.2.1 Sweet Almond Oil
  2. 4.2.2 Grapeseed Oil
  3. 4.2.3 Coconut Oil
  4. 4.2.4 Jojoba Oil
  5. 4.2.5 Sunflower Oil
3. 4.3 Packaging & Transport, BY Active Ingredient (USD Billion)
  1. 4.3.1 Essential Oils
  2. 4.3.2 Plant Extracts
  3. 4.3.3 Vitamins and Minerals
4. 4.4 Packaging & Transport, BY Target Area (USD Billion)
  1. 4.4.1 Full Body
  2. 4.4.2 Muscle Relief
  3. 4.4.3 Skin Care
  4. 4.4.4 Aromatherapy
5. 4.5 Packaging & Transport, BY Therapeutic Benefits (USD Billion)
  1. 4.5.1 Relaxation and Stress Relief
  2. 4.5.2 Pain and Inflammation Reduction
  3. 4.5.3 Improved Sleep Quality
  4. 4.5.4 Increased Circulation
  5. 4.5.5 Skin Hydration and Nourishment
6. 4.6 Packaging & Transport, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Packaging & Transport
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson's (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Neutrogena (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Burt's Bees (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 The Body Shop (GB)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Aveda (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Kiehl's (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 L'Occitane (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Weleda (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bio-Oil (ZA)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY BASE OIL
5. 6.5 US MARKET ANALYSIS BY ACTIVE INGREDIENT
6. 6.6 US MARKET ANALYSIS BY TARGET AREA
7. 6.7 US MARKET ANALYSIS BY THERAPEUTIC BENEFITS
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY BASE OIL
10. 6.10 CANADA MARKET ANALYSIS BY ACTIVE INGREDIENT
11. 6.11 CANADA MARKET ANALYSIS BY TARGET AREA
12. 6.12 CANADA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY BASE OIL
16. 6.16 GERMANY MARKET ANALYSIS BY ACTIVE INGREDIENT
17. 6.17 GERMANY MARKET ANALYSIS BY TARGET AREA
18. 6.18 GERMANY MARKET ANALYSIS BY THERAPEUTIC BENEFITS
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY BASE OIL
21. 6.21 UK MARKET ANALYSIS BY ACTIVE INGREDIENT
22. 6.22 UK MARKET ANALYSIS BY TARGET AREA
23. 6.23 UK MARKET ANALYSIS BY THERAPEUTIC BENEFITS
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY BASE OIL
26. 6.26 FRANCE MARKET ANALYSIS BY ACTIVE INGREDIENT
27. 6.27 FRANCE MARKET ANALYSIS BY TARGET AREA
28. 6.28 FRANCE MARKET ANALYSIS BY THERAPEUTIC BENEFITS
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY BASE OIL
31. 6.31 RUSSIA MARKET ANALYSIS BY ACTIVE INGREDIENT
32. 6.32 RUSSIA MARKET ANALYSIS BY TARGET AREA
33. 6.33 RUSSIA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY BASE OIL
36. 6.36 ITALY MARKET ANALYSIS BY ACTIVE INGREDIENT
37. 6.37 ITALY MARKET ANALYSIS BY TARGET AREA
38. 6.38 ITALY MARKET ANALYSIS BY THERAPEUTIC BENEFITS
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY BASE OIL
41. 6.41 SPAIN MARKET ANALYSIS BY ACTIVE INGREDIENT
42. 6.42 SPAIN MARKET ANALYSIS BY TARGET AREA
43. 6.43 SPAIN MARKET ANALYSIS BY THERAPEUTIC BENEFITS
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY BASE OIL
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY ACTIVE INGREDIENT
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY TARGET AREA
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC BENEFITS
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY BASE OIL
52. 6.52 CHINA MARKET ANALYSIS BY ACTIVE INGREDIENT
53. 6.53 CHINA MARKET ANALYSIS BY TARGET AREA
54. 6.54 CHINA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY BASE OIL
57. 6.57 INDIA MARKET ANALYSIS BY ACTIVE INGREDIENT
58. 6.58 INDIA MARKET ANALYSIS BY TARGET AREA
59. 6.59 INDIA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY BASE OIL
62. 6.62 JAPAN MARKET ANALYSIS BY ACTIVE INGREDIENT
63. 6.63 JAPAN MARKET ANALYSIS BY TARGET AREA
64. 6.64 JAPAN MARKET ANALYSIS BY THERAPEUTIC BENEFITS
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY BASE OIL
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY ACTIVE INGREDIENT
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY TARGET AREA
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY BASE OIL
72. 6.72 MALAYSIA MARKET ANALYSIS BY ACTIVE INGREDIENT
73. 6.73 MALAYSIA MARKET ANALYSIS BY TARGET AREA
74. 6.74 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY BASE OIL
77. 6.77 THAILAND MARKET ANALYSIS BY ACTIVE INGREDIENT
78. 6.78 THAILAND MARKET ANALYSIS BY TARGET AREA
79. 6.79 THAILAND MARKET ANALYSIS BY THERAPEUTIC BENEFITS
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY BASE OIL
82. 6.82 INDONESIA MARKET ANALYSIS BY ACTIVE INGREDIENT
83. 6.83 INDONESIA MARKET ANALYSIS BY TARGET AREA
84. 6.84 INDONESIA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY BASE OIL
87. 6.87 REST OF APAC MARKET ANALYSIS BY ACTIVE INGREDIENT
88. 6.88 REST OF APAC MARKET ANALYSIS BY TARGET AREA
89. 6.89 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC BENEFITS
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY BASE OIL
93. 6.93 BRAZIL MARKET ANALYSIS BY ACTIVE INGREDIENT
94. 6.94 BRAZIL MARKET ANALYSIS BY TARGET AREA
95. 6.95 BRAZIL MARKET ANALYSIS BY THERAPEUTIC BENEFITS
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY BASE OIL
98. 6.98 MEXICO MARKET ANALYSIS BY ACTIVE INGREDIENT
99. 6.99 MEXICO MARKET ANALYSIS BY TARGET AREA
100. 6.100 MEXICO MARKET ANALYSIS BY THERAPEUTIC BENEFITS
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY BASE OIL
103. 6.103 ARGENTINA MARKET ANALYSIS BY ACTIVE INGREDIENT
104. 6.104 ARGENTINA MARKET ANALYSIS BY TARGET AREA
105. 6.105 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY BASE OIL
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY ACTIVE INGREDIENT
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET AREA
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY BASE OIL
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY ACTIVE INGREDIENT
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY TARGET AREA
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC BENEFITS
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY BASE OIL
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY ACTIVE INGREDIENT
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY TARGET AREA
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY BASE OIL
124. 6.124 REST OF MEA MARKET ANALYSIS BY ACTIVE INGREDIENT
125. 6.125 REST OF MEA MARKET ANALYSIS BY TARGET AREA
126. 6.126 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC BENEFITS
127. 6.127 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF PACKAGING & TRANSPORT
130. 6.130 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
131. 6.131 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
132. 6.132 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
133. 6.133 PACKAGING & TRANSPORT, BY APPLICATION, 2024 (% SHARE)
134. 6.134 PACKAGING & TRANSPORT, BY APPLICATION, 2024 TO 2035 (USD Billion)
135. 6.135 PACKAGING & TRANSPORT, BY BASE OIL, 2024 (% SHARE)
136. 6.136 PACKAGING & TRANSPORT, BY BASE OIL, 2024 TO 2035 (USD Billion)
137. 6.137 PACKAGING & TRANSPORT, BY ACTIVE INGREDIENT, 2024 (% SHARE)
138. 6.138 PACKAGING & TRANSPORT, BY ACTIVE INGREDIENT, 2024 TO 2035 (USD Billion)
139. 6.139 PACKAGING & TRANSPORT, BY TARGET AREA, 2024 (% SHARE)
140. 6.140 PACKAGING & TRANSPORT, BY TARGET AREA, 2024 TO 2035 (USD Billion)
141. 6.141 PACKAGING & TRANSPORT, BY THERAPEUTIC BENEFITS, 2024 (% SHARE)
142. 6.142 PACKAGING & TRANSPORT, BY THERAPEUTIC BENEFITS, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.2.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.2.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.2.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.3.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.3.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.3.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.4.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.4.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.4.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.5.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.5.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.5.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.6.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.6.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.6.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.7.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.7.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.7.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.8.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.8.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.8.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.9.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.9.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.9.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.10.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.10.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.10.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.11.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.11.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.11.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.12.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.12.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.12.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.13.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.13.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.13.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.14.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.14.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.14.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.15.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.15.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.15.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.16.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.16.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.16.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.17.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.17.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.17.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.18.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.18.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.18.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.19.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.19.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.19.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.20.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.20.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.20.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.21.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.21.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.21.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.22.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.22.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.22.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.23.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.23.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.23.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.24.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.24.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.24.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.25.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.25.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.25.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.26.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.26.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.26.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.27.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.27.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.27.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.28.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.28.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.28.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.29.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.29.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.29.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY BASE OIL, 2025-2035 (USD Billion)
  3. 7.30.3 BY ACTIVE INGREDIENT, 2025-2035 (USD Billion)
  4. 7.30.4 BY TARGET AREA, 2025-2035 (USD Billion)
  5. 7.30.5 BY THERAPEUTIC BENEFITS, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Packaging & Transport Market Segmentation

Packaging & Transport By Application (USD Billion, 2025-2035)

Professional Massage
Personal Massage
Beauty and Spa Treatments

Packaging & Transport By Base Oil (USD Billion, 2025-2035)

Sweet Almond Oil
Grapeseed Oil
Coconut Oil
Jojoba Oil
Sunflower Oil

Packaging & Transport By Active Ingredient (USD Billion, 2025-2035)

Essential Oils
Plant Extracts
Vitamins and Minerals

Packaging & Transport By Target Area (USD Billion, 2025-2035)

Full Body
Muscle Relief
Skin Care
Aromatherapy

Packaging & Transport By Therapeutic Benefits (USD Billion, 2025-2035)

Relaxation and Stress Relief
Pain and Inflammation Reduction
Improved Sleep Quality
Increased Circulation
Skin Hydration and Nourishment

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”